A recent discovery could help individuals with type 2 diabetes find out if they are at risk of developing heart and kidney disease.
Scientists have developed a straightforward blood test that identifies key signs linked to these diseases.
This blood test could lead to early detection, better treatment, and improved outcomes for people with diabetes.
Type 2 diabetes is a common condition that affects how our bodies manage sugar (glucose). It can increase the risk of heart and kidney problems.
These complications often occur silently, with no obvious symptoms until they become severe. Identifying them early is crucial for preventing serious health issues.
Scientists have discovered that certain molecules in our blood, called biomarkers, can give us clues about our health.
By measuring these biomarkers, doctors can detect early signs of diseases like heart and kidney conditions.
Researchers examined blood samples from 2,627 people with type 2 diabetes. They were part of a study called CREDENCE, which aimed to see if a specific medication, canagliflozin, could help.
In addition to studying the medication, the researchers looked at four biomarkers in the blood.
Strong Predictions: High levels of the four biomarkers in the blood at the start of the study were linked to more severe heart and kidney issues in the participants. This suggests that these biomarkers could serve as warning signs.
Treatment Benefits: Participants who took canagliflozin had lower levels of these biomarkers after one and three years compared to those who didn’t take the medication. This indicates that the medication may help reduce the risk of heart-related hospitalizations.
Early Detection: The study results highlight the importance of finding high-risk patients early. By doing so, healthcare professionals can take steps to prevent heart and kidney problems from getting worse.
Promise for the Future: This new blood test has the potential to make a big difference for people with type 2 diabetes.
It can help doctors identify those at risk and take action before complications become severe. Early detection and treatment can improve patients’ quality of life and reduce the impact of heart and kidney diseases.
The blood test and the biomarkers it measures offer hope for better healthcare for people with type 2 diabetes.
By catching issues early and personalizing treatments, doctors can work to keep patients healthier and improve their chances of a long and active life.
If you care about kidney health, please read studies about pesticide linked to chronic kidney disease, and this drug may prevent kidney failure in people with diabetes.
For more information about kidney health, please see recent studies about drug duo that may treat kidney failure, and results showing these vegetables may protect against kidney damage.
The research findings can be found in Circulation.
Copyright © 2023 Knowridge Science Report. All rights reserved.